ID Q08495; PN Dematin; GN DMTN; OS 9606; SL Nucleus Position: SL-0198; SL Comments: Cytoplasm. Cytoplasm, cytosol. Cytoplasm, perinuclear region {ECO:0000250}. Cytoplasm, cytoskeleton. Cell membrane. Membrane {ECO:0000250}. Endomembrane system. Cell projection {ECO:0000250}. Note=Localized at the spectrin-actin junction of erythrocyte plasma membrane. Localized to intracellular membranes and the cytoskeletal network. Localized at intracellular membrane-bounded organelle compartment in platelets that likely represent the dense tubular network membrane. Detected at the cell membrane and at the parasitophorous vacuole in malaria-infected erythrocytes at late stages of plasmodium berghei or falciparum development. DR UNIPROT: Q08495; DR UNIPROT: A8K0T5; DR UNIPROT: B3KP70; DR UNIPROT: B3KRH3; DR UNIPROT: B4DI75; DR UNIPROT: E9PEJ0; DR UNIPROT: Q13215; DR UNIPROT: Q9BRE3; DR PDB: 1QZP; DR PDB: 1ZV6; DR Pfam: PF16182; DR Pfam: PF02209; DR PROSITE: PS51089; DR OMIM: 125305; DR DisGeNET: 2039; DE Function: Membrane-cytoskeleton-associated protein with F-actin-binding activity that induces F-actin bundles formation and stabilization. Its F-actin-bundling activity is reversibly regulated upon its phosphorylation by the cAMP-dependent protein kinase A (PKA). Binds to the erythrocyte membrane glucose transporter-1 SLC2A1/GLUT1, and hence stabilizes and attaches the spectrin-actin network to the erythrocytic plasma membrane. Plays a role in maintaining the functional integrity of PKA-activated erythrocyte shape and the membrane mechanical properties. Also plays a role as a modulator of actin dynamics in fibroblasts; acts as a negative regulator of the RhoA activation pathway. In platelets, functions as a regulator of internal calcium mobilization across the dense tubular system that affects platelet granule secretion pathways and aggregation. Also required for the formation of a diverse set of cell protrusions, such as filopodia and lamellipodia, necessary for platelet cell spreading, motility and migration. Acts as a tumor suppressor and inhibits malignant cell transformation. {ECO:0000269|PubMed:10565303, ECO:0000269|PubMed:11856323, ECO:0000269|PubMed:18347014, ECO:0000269|PubMed:19241372, ECO:0000269|PubMed:22927433, ECO:0000269|PubMed:23355471}. DE Reference Proteome: Yes; DE Interaction: O43237; IntAct: EBI-731827; Score: 0.00 DE Interaction: Q9UNN8; IntAct: EBI-734445; Score: 0.00 DE Interaction: Q86YD1; IntAct: EBI-735504; Score: 0.00 DE Interaction: P62316; IntAct: EBI-736673; Score: 0.00 DE Interaction: P31946; IntAct: EBI-8796749; Score: 0.35 DE Interaction: P14618; IntAct: EBI-9355736; Score: 0.44 DE Interaction: Q08379; IntAct: EBI-10225555; Score: 0.56 DE Interaction: Q8TAP6; IntAct: EBI-24382670; Score: 0.56 DE Interaction: Q8IYF3; IntAct: EBI-24387259; Score: 0.56 DE Interaction: Q12933; IntAct: EBI-24472525; Score: 0.56 DE Interaction: Q8IWV7; IntAct: EBI-21864310; Score: 0.35 DE Interaction: Q86TI2; IntAct: EBI-21864310; Score: 0.35 DE Interaction: P63104; IntAct: EBI-21864310; Score: 0.35 DE Interaction: P62258; IntAct: EBI-21864310; Score: 0.35 DE Interaction: P61981; IntAct: EBI-21864310; Score: 0.35 DE Interaction: Q04917; IntAct: EBI-21907689; Score: 0.35 DE Interaction: P50552; IntAct: EBI-30845230; Score: 0.44 GO GO:0015629; GO GO:0005884; GO GO:0031253; GO GO:0030863; GO GO:0031410; GO GO:0005829; GO GO:0012505; GO GO:0048471; GO GO:0005886; GO GO:0031095; GO GO:0014069; GO GO:0014731; GO GO:0003779; GO GO:0051015; GO GO:0043621; GO GO:0005102; GO GO:0030507; GO GO:0030036; GO GO:0051017; GO GO:0051693; GO GO:0090527; GO GO:0035585; GO GO:0035584; GO GO:0071277; GO GO:0071320; GO GO:0007010; GO GO:0048821; GO GO:0030032; GO GO:0010812; GO GO:0051895; GO GO:0033137; GO GO:0010801; GO GO:0050732; GO GO:0090315; GO GO:1900025; GO GO:0030194; GO GO:0010763; GO GO:2001046; GO GO:1901731; GO GO:1900026; GO GO:0090303; GO GO:0070560; GO GO:0065003; GO GO:0032956; GO GO:0008360; GO GO:0051489; GO GO:0010591; TP Membrane Topology: Unknown; Source: UniProt - Sequence Analysis; SQ MERLQKQPLTSPGSVSPSRDSSVPGSPSSIVAKMDNQVLGYKDLAAIPKDKAILDIERPDLMIYEPHFTYSLLEHVELPR SQ SRERSLSPKSTSPPPSPEVWADSRSPGIISQASAPRTTGTPRTSLPHFHHPETSRPDSNIYKKPPIYKQRESVGGSPQTK SQ HLIEDLIIESSKFPAAQPPDPNQPAKIETDYWPCPPSLAVVETEWRKRKASRRGAEEEEEEEDDDSGEEMKALRERQREE SQ LSKVTSNLGKMILKEEMEKSLPIRRKTRSLPDRTPFHTSLHQGTSKSSSLPAYGRTTLSRLQSTEFSPSGSETGSPGLQN SQ GEGQRGRMDRGNSLPCVLEQKIYPYEMLVVTNKGRTKLPPGVDRMRLERHLSAEDFSRVFAMSPEEFGKLALWKRNELKK SQ KASLF //